Drug Safety expert proficient with the latest and upcoming trends in drug safety required for long term advanced safety analytics advisory. An RNA based platform with multiple indications, applying advanced safety analytics to support the entire portfolio, as opposed to only one indication at a time, is a core strategy for the drug sponsor. Expert […]
READ MORE
Drug Safety Scientist required at 30% of FDA. Must be expert in drug safety statistics. For the particular asset under development the safety profile is extremely strategic. The main competitor product’s safety profile is not ideal but since there are no other treatments it is the primary product for this condition. This asset has similar […]
READ MORE
1200 word content write up of 2023 Decentralized Clinical Trials predictions. Primary input- interview of thought leader, plus individual DCT trends research. To be published in pharmaceutical trade journal.
READ MORE
Trial projections indicate that too much supply is being utilized in the current dose administration methods used. Need an expert to advice on supply best practices such that product is being utilized more efficiently. Thinking a clinical affairs/trial design/clinical supply expert or perhaps even a clinician or nurse specialist could solve this issue for us. […]
READ MORE